These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2117818)

  • 1. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts.
    Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ
    Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content.
    Tyerman K; Barron PT; Da Costa M; McCleish M; Fulford A; Collier SJ; Thiru S
    Transplant Proc; 1990 Oct; 22(5):2325. PubMed ID: 2219389
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II antigen expression on vascular endothelium of the graft in rat heart transplantation.
    Bouwman E; IJzermans JN; Heineman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):198-9. PubMed ID: 3152687
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of class II major histocompatibility complex antigen induction in cyclosporine A--treated recipients of heart and kidney allografts in the rat.
    Milton AD; Spencer SC; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):192-4. PubMed ID: 3152686
    [No Abstract]   [Full Text] [Related]  

  • 8. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts.
    Klempnauer J; Steiniger B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182
    [No Abstract]   [Full Text] [Related]  

  • 9. The induction of class II antigens by interferon-gamma and its relevance for the acute rejection of allografts.
    IJzermans JN; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):244-5. PubMed ID: 3152697
    [No Abstract]   [Full Text] [Related]  

  • 10. Donor pretreatment prolongs survival of discordant xenografts.
    Jefferson KP; Tyerman KS; McLeish M; Collier DS; Thiru S
    Transplant Proc; 1991 Aug; 23(4):2280-1. PubMed ID: 1871871
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of combined treatment with total lymphoid irradiation, cyclosporin A, and anti-CD4 monoclonal antibodies in a hamster-to-rat heart transplantation model.
    Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
    Transplant Proc; 1991 Feb; 23(1 Pt 1):579-80. PubMed ID: 1990614
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged rat heart allograft survival and reduced graft immunogenicity after photochemical donor and transplant pretreatment.
    Oesterwitz H; Eichler C; Schneider W; Kaden J
    Z Versuchstierkd; 1989; 32(2):77-82. PubMed ID: 2667272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat.
    Romaniuk A; Ryffa T; Rowiński W; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):253-60. PubMed ID: 2639625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked differences between orthotopic and heterotopic auxiliary liver allografts in the induction of class II MHC antigens on hepatocytes.
    Icard P; Sawyer GJ; Houssin D; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1935. PubMed ID: 2117820
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival.
    Sone Y; Sakagami K; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
    Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of donor conditioning with cyclosporin on the survival time of allogenic heart transplants in the rat].
    Oesterwitz H; Gruner S; Schneider W
    Z Exp Chir Transplant Kunstliche Organe; 1989; 22(5):282-5. PubMed ID: 2588745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.